Therapeutic targets and molecules
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 16, 2012
Grant Date -
May 6, 2010
app pub date -
Mar 26, 2008
filing date -
Mar 26, 2007
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention provides methods and compositions for treating or preventing inflammation or an inflammatory condition in a subject, comprising administering to the subject an effective amount of at least one antagonist of one or more miRNA upregulated in inflammatory disease conditions and response to allergen challenge. The invention also provides methods for diagnosing inflammatory conditions based on miRNA expression profile signatures.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully